Micotherapy BM

Micotherapy BM è un integratore che contiene Ganoderma lucidum da agricoltura biologica, Hypericum perforatum, Centella asiatica, Passiflora incarnata e vitamine del gruppo B, utile in caso di elevata percezione dello stress, situazioni ansioso-depressive, insonnia, sbalzi di umore e irritabilità

Formato

60 capsule acido-resistenti DRcaps™

Mdo d'uso

2-4 capsule al giorno

Proprietà

Grazie alla sinergia dei suoi componenti Micotherapy BM unisce la tradizione millenaria di utilizzo della micoterapia con l’efficacia e la rapidità di azione della fitoterapia tradizionale. Micotherapy BM favorisce l’azione del sistema parasimpatico, senza indurre sonnolenza, ma migliorando il controllo dello stress, l’ansia e il nervosismo oltre alla qualità del sonno e alla lucidità mentale. Grazie alla presenza di Iperico, Centella e Passiflora, Micotherapy BM agisce migliorando la biodisponibilità dei neurotrasmettitori serotonina, dopamina e GABA, modulandone la ricaptazione a livello sinaptico.

Effetti principali

Favorisce il rilassamento e il benessere mentale, contribuendo a migliorare l’equilibrio psicofisico, il tono dell’umore e ritmi del sonno

Informazioni nutrizionali

Componenti

Per dosaggio giornaliero

Reishi estr. secco 660 mg
Apporto in polisaccaridi 165 mg
Grano saraceno 400 mg
Iperico estr. secco 234 mg
Apporto giornaliero di Ipericina 0,7 mg
Rapporto iperforine/ipericina non superiore a 7
Passiflora estr. secco 200 mg
Centella estr. secco 100 mg
Vitamina B1 (tiamina) 0,8 mg
Vitamina B2 (riboflavina) 1,3 mg
Vitamina B3 (niacina) 14,3 mg
Vitamina B5 (ac. pantotenico) 5,5 mg
Vitamina B6 (piridossina) 0,8 mg
Acido folico 180 mcg
Vitamina B12 (cianocobalamina) 1,6 mcg
Reperibilità prodotto

Codice parafarmaco: A925603779

Inserito nel registro degli integratori n°: codice 71757

Note:

le sostanze presenti nell’Hypericum perforatum possono interagire con diversi enzimi responsabili del metabolismo dei farmaci. Si consiglia di consultare il medico prima di assumere preparazioni a base di iperico insieme ad altri farmaci

Mizuno, T. (1996). Oriental Medicinal tradition of “Ganoderma lucidum (Reishi)” in China. In T. Mizuno & B.-K. Kim(Eds.), Ganoderma lucidum (pp. 101-106). Seoul, Korea : IlYang Pharm. Co. Ltd

Kim KC, Kim IG. Ganoderma lucidum extract protects DNA from strand breakage caused by hydroxyl radical and UV irradiation. Int J Mol Med 1999 Sep;4(3):273-7

Wachtel-Galor S, Szeto YT, Tomlinson B, et al. Ganoderma lucidum (‘Lingzhi’); acute and short-term biomarker response to supplementation. Int J Food Sci Nutr. Feb 2004;55(1):75-83

T.A. Ajith, N.P. Sudheesh, D. Roshny, G. Abishek and K.K. Janardhanan. Effect of Ganoderma lucidum on the activities of mitochondrial dehydrogenases and complex I and II of electron transport chain in the brain of aged rats Experimental Gerontology Volume 44, Issue 3, March 2009, Pages 219-223

Tang W, Gao Y, Chen G, et al. A Randomized, Double-Blind and Placebo-Controlled Study of a Ganoderma lucidum Polysaccharide Extract in Neurasthenia. J Med Food. 2005;8:53-58

CS Lai, MS Yu, WH Yuen, KF So, SY Zee, and RC Chang. Antagonizing beta-amyloid peptide neurotoxicity of the anti-aging fungus Ganoderma lucidum. Brain Res, Jan 2008; 1190: 215-24

R Zhang, S Xu, Y Cai, M Zhou, X Zuo and P Chan. Ganoderma lucidum Protects Dopaminergic Neuron Degeneration Through Inhibition of Microglial Activation. eCAM Advance Access published July 16, 2009

ZY Zhou, YP Tang, J Xiang, P Wua, HM Jin, Z Wang, M Mori, and DF Cai. Neuroprotective effects of water-soluble Ganoderma lucidum polysaccharides on cerebral ischemic injury in rats. J Ethnopharmacol, August 19, 2010; 131(1): 154-64

Zhou Y, Qu ZQ, Zeng YS, Lin YK, Li Y, Chung P, Wong R, Hagg U. Neuroprotective effect of preadministration with Ganoderma lucidum spore on rat hippocampus. Exp Toxicol Pathol, November 1, 2012; 64(7-8): 673-80

Ajith TA et al. Effect of Ganoderma lucidum on the activities of mitochondrial dehydrogenases and complex I and II of electron transport chain in the brain of aged rats. ExpGerontol 2009; 44(3):219-223

Ding H, et al. Ganoderma lucidum extract protects dopaminergic neurons through inhibiting the production of inflammatory mediators by activated microglia. Sheng Li Xue Bao. 2010 Dec 25;62(6):547-54

Zhao HB, et al. Polysaccharide extract isolated from ganoderma lucidum protects rat cerebral cortical neurons from hypoxia/reoxygenation injury. J Pharmacol Sci. 2004 Jun;95(2):294-8

Zhang R, et al. Ganoderma lucidum protects dopaminergic neuron degeneration through inhibition of microglial activation. Evid Based Complement Alternat Med. 2011;2011:156810

Chen LW, Horng LY, Wu CL, Sung HC, Wu RT. Activating mitochondrial regulator PGC-1alpha expression by astrocytic NGF is a therapeutic strategy for Huntington’s disease. Neuropharmacology. 2012 May 24

XY Cui, SY Cui, J Zhang, ZJ Wang, B Yu, ZF Sheng, XQ Zhang, and YH Zhang Extract of Ganoderma lucidum prolongs sleep time in rats. J Ethnopharmacol, February 15, 2012; 139(3): 796-800

Lee JM et al. Inhibition of lipid peroxidation and oxidative DNA damage by Ganoderma lucidum. Phytotherapy Res; 15: 245-249

Campanini E. – “ Dizionario di fitoterapia e piante medicinali”– Milano, 2012

Fassina G. – “Lezioni di farmacologia”- Cedam, Padova, 1995

Speroni E. et al. Neuropharmacological activity of extracts from Passiflora incarnata. Planta Med. 54, 488-491, 1988

Bourin A.V. et al. A combination of plant extracts in the treatment of outpatients with adjustement disorders with anxious mood. Controlled study versus placebo. Fundam. Clin. Pharmacol. 11, 127-132, 1997

Speroni E. et al. Role of chrisin in the sedative effects of Passiflora incarnata L. Phytother. Res. 10, suppl. 1, S 98- S 100, 1996

Speroni E. et al. Sedative effects of crude extracts of Passiflora incarnata after oral administration. Phytother. Res. 10, suppl. 1, S 92-S 94, 1996

Dhawan K. et al. Anxiolytic activity of aerial and underground parts of Passiflora incarnata. Fitoterapia 72, 922-926, 2001

Dhawan K. et al. Anti-anxiety studies on extracts of Passiflora incarnata Linneaus. J. Ethnopharmacol. 78, 165-170, 2001

Akhondzadek S. et al. Passionflower in the treatment of generalized anxiety: a pilot double blind randomized controlled trial with oxazepam. J. Clin. Pharm. Ther. 26, 363-377, 2001

Dhawan K. et al. Comparative Anxiolytic Activity Profile of Various Preparations of Passiflora incarnata Linneaus: A Comment on Medicinal Plants’ Standardization. J Altern Complement Med 8(3):283-91, 2002

A Szegedi, R Kohnen, A Dienel, M Kieser. Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John’s wort): randomised controlled double blind non-inferiority trial versus paroxetine. BMJ 2005;330:503

Monograph. Hypericum perforatum. Altern Med Rev. 2004 Sep; 9 (3):318-25

Linde K, Mulrow CD, Berner M, Egger M. St John’s worth for depression. Cochrane Database Syst Rev. 2005 Apr 18;(2):CD000448

James, J.T.; Dubery, I.A. Pentacyclic Triterpenoids from the Medicinal Herb, Centella asiatica (L.) Urban. Molecules 2009, 14, 3922-3941

Blumenthal M et al. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Klein S, Rister RS, translators. Austin (TX): American Botanical Council; Boston (MA): Integrative Medicine Communications; 1998

Linee prodotti